AVITA Medical: PermeaDerm-I trial finds PermeaDerm comparable to cadaveric allograft, cutting treatment cost about 70% and significantly reducing preparation time
https://finviz.com/stock?t=RCEL&p=d
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.